Cargando…
Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
BACKGROUND: Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) gl...
Autores principales: | Rosenfeld, Elizabeth, Nanga, Ravi Prakash Reddy, Lucas, Alfredo, Revell, Andrew Y., Thomas, Allison, Thomas, Nina H., Roalf, David R., Shinohara, Russel T., Reddy, Ravinder, Davis, Kathryn A., De León, Diva D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233810/ https://www.ncbi.nlm.nih.gov/pubmed/35752848 http://dx.doi.org/10.1186/s13023-022-02398-3 |
Ejemplares similares
-
Correction: Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2022) -
MON-110 Utilization of GluCEST, a Novel Neuroimaging Technique, to Characterize the Brain Phenotype in Hyperinsulinism/Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2020) -
Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome
por: Boodhansingh, Kara E., et al.
Publicado: (2022) -
OR05-2 Targeted Inhibition of Glutamate Dehydrogenase by Alpha-Tocopherol: A Potential Novel Treatment for Hyperinsulinism Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2019) -
Hyperinsulinism-hyperammonemia Syndrome in An Infant with Seizures
por: Strajnar, A, et al.
Publicado: (2018)